These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 36569869)

  • 1. Molecular characterization of immunogenic cell death indicates prognosis and tumor microenvironment infiltration in osteosarcoma.
    Liu Z; Liu B; Feng C; Li C; Wang H; Zhang H; Liu P; Li Z; He S; Tu C
    Front Immunol; 2022; 13():1071636. PubMed ID: 36569869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classification related to immunogenic cell death predicts prognosis, immune microenvironment characteristics, and response to immunotherapy in lower-grade gliomas.
    Kuang Y; Jiang B; Zhu H; Zhou Y; Huang H; Li C; Zhang W; Li X; Cao Y
    Front Immunol; 2023; 14():1102094. PubMed ID: 37153540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenic cell death-related classifications guide prognosis and immunotherapy in osteosarcoma.
    Zong Y; Cao Y; Zhang D; Guan X; Zhang F; Shen Z; Yin F
    Sci Rep; 2023 Jun; 13(1):9118. PubMed ID: 37277499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel immunogenic cell death-related genes signature for predicting prognosis, immune landscape and immunotherapy effect in hepatocellular carcinoma.
    Xu G; Jiang Y; Li Y; Ge J; Xu X; Chen D; Wu J
    J Cancer Res Clin Oncol; 2023 Dec; 149(18):16261-16277. PubMed ID: 37698679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of Prognosis and Immunotherapy Response with a Novel Natural Killer Cell Marker Genes Signature in Osteosarcoma.
    Li Q; Huang X; Zhao Y
    Cancer Biother Radiopharm; 2024 Sep; 39(7):502-516. PubMed ID: 37889617
    [No Abstract]   [Full Text] [Related]  

  • 6. Development and verification of a novel immunogenic cell death-related signature for predicting the prognosis and immune infiltration in triple-negative breast cancer.
    Li J; Li Z; Yang W; Pan J; You H; Yang L; Zhang X
    Cancer Rep (Hoboken); 2024 Mar; 7(3):e2007. PubMed ID: 38425247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of the immunogenic cell death-related signature for predicting prognosis and immunotherapy efficiency in patients with lung adenocarcinoma.
    Cui Y; Li Y; Long S; Xu Y; Liu X; Sun Z; Sun Y; Hu J; Li X
    BMC Med Genomics; 2023 Aug; 16(1):184. PubMed ID: 37553698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenic cell death related mRNAs associated signature to predict immunotherapeutic response in osteosarcoma.
    Han S; Wang Q; Shen M; Zhang X; Wang J
    Heliyon; 2024 Mar; 10(6):e27630. PubMed ID: 38515694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Immunogenic Cell-Death-Related Subtypes and Development of a Prognostic Signature in Gastric Cancer.
    Gan X; Tang X; Li Z
    Biomolecules; 2023 Mar; 13(3):. PubMed ID: 36979463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Definition of a Novel Immunogenic Cell Death-Relevant Gene Signature Associated with Immune Landscape in Gastric Cancer.
    Meng Y; Jin Z; Wang M; Chen D; Zhu M; Huang Y; Xia S; Xiong Z
    Biochem Genet; 2023 Oct; 61(5):2092-2115. PubMed ID: 36943521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An immunogenic cell death-related signature predicts prognosis and immunotherapy response in stomach adenocarcinoma.
    Liu Z; Sun L; Peng X; Liu S; Zhu Z; Huang C
    Apoptosis; 2023 Dec; 28(11-12):1564-1583. PubMed ID: 37580435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Necrotizing apoptosis-related genes prognosis and treatment effect analysis of osteosarcoma in children.
    Chen Y; Wu L; Li Y; Zheng J; Zhong S; Gu S; Chen J
    J Gene Med; 2024 Jan; 26(1):e3646. PubMed ID: 38100138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated transcriptomic analysis systematically reveals the heterogeneity and molecular characterization of cancer-associated fibroblasts in osteosarcoma.
    Liu Y; Han X; Han Y; Bi J; Wu Y; Xiang D; Zhang Y; Bi W; Xu M; Li J
    Gene; 2024 May; 907():148286. PubMed ID: 38367852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel immune cell signature for predicting osteosarcoma prognosis and guiding therapy.
    Pan R; Pan F; Zeng Z; Lei S; Yang Y; Yang Y; Hu C; Chen H; Tian X
    Front Immunol; 2022; 13():1017120. PubMed ID: 36189307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-omics identification of an immunogenic cell death-related signature for clear cell renal cell carcinoma in the context of 3P medicine and based on a 101-combination machine learning computational framework.
    Liu J; Shi Y; Zhang Y
    EPMA J; 2023 Jun; 14(2):275-305. PubMed ID: 37275552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of immunogenic cell death-related subtypes used for predicting survival and immunotherapy of endometrial carcinoma through a bioinformatics analysis.
    Liu Z; Luo Y; Su L; Hu X
    Medicine (Baltimore); 2023 Aug; 102(31):e34571. PubMed ID: 37543760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of cuproptosis-related lncRNA prognostic signature for osteosarcoma.
    Liu B; Liu Z; Feng C; Li C; Zhang H; Li Z; Tu C; He S
    Front Endocrinol (Lausanne); 2022; 13():987942. PubMed ID: 36313774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis of colorectal cancer, prognostic index of immunogenic cell death associated genes in response to immunotherapy, and potential therapeutic effects of ferroptosis inducers.
    Lei M; Xiao M; Long Z; Lin T; Ding R; Quan Q
    Front Immunol; 2024; 15():1458270. PubMed ID: 39372411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comprehensive analysis of immunogenic cell death and its key gene HSP90AA1 in bladder cancer.
    Song Q; Zhou Z; Bai J; Liu N
    Clin Transl Oncol; 2023 Aug; 25(8):2587-2606. PubMed ID: 37000291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of an immunogenic cell death-related gene signature predicts survival and sensitivity to immunotherapy in clear cell renal carcinoma.
    Zhou S; Lu Y; Chen Y; Gan W
    Sci Rep; 2023 Mar; 13(1):4449. PubMed ID: 36932108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.